📄 "KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models" . KSHV/HHV-8 ( July 1, 2026 at 11:03PM)
https://pubmed.ncbi.nlm.nih.gov/42384773/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260701220310&v=2.20.0

📄 "CD44 expression associates with EBV LMP1, reduced CD8+ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma" . EBV ( June 30, 2026 at 12:15PM)
https://pubmed.ncbi.nlm.nih.gov/42374504/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260630111542&v=2.20.0

📄 "Epstein-Barr Virus-host epigenetic interplay: mechanisms of regulation and therapeutic potential" . EBV ( July 7, 2026 at 04:35AM)
https://pubmed.ncbi.nlm.nih.gov/42410445/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260707033546&v=2.20.0

📄 "Prevalence of Epstein-Barr virus infection in North African cancer patients: a systematic review and meta-analysis protocol" . Vírus e Câncer ( July 9, 2026 at 09:08AM)
https://pubmed.ncbi.nlm.nih.gov/42421079/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260709080838&v=2.20.0

📄 "The Complex Interplay of Malaria and EBV in Burkitt Lymphoma" . EBV ( July 15, 2026 at 02:09PM)
https://pubmed.ncbi.nlm.nih.gov/42449688/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260715130921&v=2.20.0

📄 "BFLF1 gene polymorphisms are associated with increased mortality in patients with EBV-associated diseases" . EBV ( July 15, 2026 at 02:09PM)
https://pubmed.ncbi.nlm.nih.gov/42449423/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260715130921&v=2.20.0

📄 "Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts" . Vírus e Câncer ( July 16, 2026 at 05:03AM)
https://pubmed.ncbi.nlm.nih.gov/42457673/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260716040331&v=2.20.0

📄 "Repression of productive viral replication by KSHV LANA correlates with reduced adaptive immune activation: potential implications for KSHV immune evasion" . KSHV/HHV-8 ( July 23, 2026 at 03:56PM)
https://pubmed.ncbi.nlm.nih.gov/42489446/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260723145629&v=2.20.0

📄 "Mechanistic interactions between Plasmodium falciparum and Epstein-Barr virus in endemic Burkitt Lymphoma pathogenesis: a narrative review (2010-2026)" . EBV ( July 16, 2026 at 10:12AM)
https://pubmed.ncbi.nlm.nih.gov/42458528/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260716091202&v=2.20.0

📄 "Systematic investigation reveals extensive Epstein-Barr virus transcriptional regulation of the human genome" . EBV ( July 16, 2026 at 02:01AM)
https://pubmed.ncbi.nlm.nih.gov/42456663/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260716010141&v=2.20.0

📄 "Clinical outcomes of Epstein-Barr virus infection/reactivation following CAR-T cell therapy: A systematic review" . EBV ( July 14, 2026 at 08:04AM)
https://pubmed.ncbi.nlm.nih.gov/42442615/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260714070421&v=2.20.0

📄 "Exosomal miRNA expression in transplant recipients with EBV-associated post-transplant lymphoproliferative disorder" . EBV ( July 25, 2026 at 10:26AM)
https://pubmed.ncbi.nlm.nih.gov/42500680/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260725092609&v=2.20.0

📄 "Editorial: EBV strategies to counteract the immune response" . EBV ( July 10, 2026 at 08:12AM)
https://pubmed.ncbi.nlm.nih.gov/42427490/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260710071210&v=2.20.0

📄 "Burden of Epstein-Barr virus in gastric cancer, nasopharyngeal carcinoma, and Burkitt lymphoma in Africa: a systematic review and meta-analysis" . EBV ( July 10, 2026 at 08:12AM)
https://pubmed.ncbi.nlm.nih.gov/42426668/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260710071210&v=2.20.0

📄 "The EBV timing hypothesis: How the age of primary infection may explain global variation in multiple sclerosis" . EBV ( July 8, 2026 at 10:15PM)
https://pubmed.ncbi.nlm.nih.gov/42418890/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260708211511&v=2.20.0

📄 "Morphological CT signs of Epstein-Barr virus-associated locally advanced gastric cancer: a radiological-pathological comparison study" . Vírus e Câncer ( July 31, 2026 at 03:16AM)
https://pubmed.ncbi.nlm.nih.gov/42531883/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260731021559&v=2.20.0.post5+40e1b98

📄 "Classic Hodgkin Lymphoma: A Review" . Hodgkin Lymphoma ( August 3, 2026 at 10:18PM)
https://pubmed.ncbi.nlm.nih.gov/42545803/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0CUstBEDbvOGq_tqA_t3HVG7jIAKeQGzpDpJpTMG8cx&fc=None&ff=20260803211823&v=2.20.0.post5+40e1b98

📄 "In-depth characterisation of the tumour microenvironment reveals HHV-8-dependent immune regulation in HIV-associated and classic Kaposi sarcoma" . Kaposi sarcoma ( August 5, 2026 at 10:35AM)
https://pubmed.ncbi.nlm.nih.gov/42552365/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=05yifUa2pTU7WbtETWIT04jseH79Lwcx090mvFUkObK&fc=None&ff=20260805093557&v=2.20.0.post5+40e1b98

📄 "Epstein-Barr Virus-Associated HMGB1-Extracellular Vesicles Facilitate Macrophage PD-L1 Expression and Tumor Metastasis" . ⭐ Virus and Cancer Progression ( August 3, 2026 at 09:59AM)
https://pubmed.ncbi.nlm.nih.gov/42544030/?utm_source=Feedly&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1ru3PjCROMN0-DCYXXwG3ZQiiaCRebQ72s7IemRCfW7HQFT5bF&fc=20250206153036&ff=20260803085920&v=2.20.0.post5+40e1b98

📄 "Downregulation of GSDMB by EBV-encoded miR-BART12-3p suppresses killer lymphocyte-mediated pyroptosis in gastric cancer cells" . EBV ( August 5, 2026 at 09:23PM)
https://pubmed.ncbi.nlm.nih.gov/42555663/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260805202355&v=2.20.1

📄 "Mechanisms of Epstein-Barr virus-associated autoimmunity: a comparative overview" . EBV ( August 5, 2026 at 08:33AM)
https://pubmed.ncbi.nlm.nih.gov/42553300/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260805073341&v=2.20.0.post5+40e1b98